Involvement of R-Ras and Ral GTPases in estrogen-independent proliferation of breast cancer cells (Q28208373)

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205961

7 January 2021

Ral and Rab3a are major GTP-binding proteins of axonal rapid transport and synaptic vesicles and do not redistribute following depolarization stimulated synaptosomal exocytosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205961

7 January 2021

c-Src, receptor tyrosine kinases, and human cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205961

7 January 2021

Rap1 signalling: adhering to new models

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205961

7 January 2021

The brain exocyst complex interacts with RalA in a GTP-dependent manner: identification of a novel mammalian Sec3 gene and a second Sec15 gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205961

7 January 2021

Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205961

7 January 2021

The GTPase Rap1 controls functional activation of macrophage integrin alphaMbeta2 by LPS and other inflammatory mediators

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205961

7 January 2021

Minimal Ras-binding domain of Raf1 can be used as an activation-specific probe for Ras.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205961

7 January 2021

Constitutive Raf-1 kinase activity in breast cancer cells induces both estrogen-independent growth and apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205961

7 January 2021

Establishment and characterisation of a new tumorigenic cell line with a normal karyotype derived from a human breast adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205961

7 January 2021

An EGF receptor/Ral-GTPase signaling cascade regulates c-Src activity and substrate specificity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205961

7 January 2021

p130Cas regulates the activity of AND-34, a novel Ral, Rap1, and R-Ras guanine nucleotide exchange factor.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205961

7 January 2021

Ral GTPases contribute to regulation of cyclin D1 through activation of NF-kappaB.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205961

7 January 2021

Acquired tamoxifen resistance in human breast cancer--potential mechanisms and clinical implications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205961

7 January 2021

Transfection of v-rasH DNA into MCF-7 human breast cancer cells bypasses dependence on estrogen for tumorigenicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205961

7 January 2021

R-Ras signals through specific integrin alpha cytoplasmic domains to promote migration and invasion of breast epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205961

7 January 2021

MCF-7 breast cancer cells overexpressing transfected c-erbB-2 have an in vitro growth advantage in estrogen-depleted conditions and reduced estrogen-dependence and tamoxifen-sensitivity in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205961

7 January 2021

R-Ras can activate the phosphoinositide 3-kinase but not the MAP kinase arm of the Ras effector pathways.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205961

7 January 2021

The exocyst is a Ral effector complex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205961

7 January 2021

Epsin binds to the EH domain of POB1 and regulates receptor-mediated endocytosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205961

7 January 2021

Up-regulation of Akt3 in estrogen receptor-deficient breast cancers and androgen-independent prostate cancer lines.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205961

7 January 2021

Activation of brain B-Raf protein kinase by Rap1B small GTP-binding protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205961

7 January 2021

Ral-GTPase influences the regulation of the readily releasable pool of synaptic vesicles.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205961

7 January 2021

Specificity within the EGF family/ErbB receptor family signaling network

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205961

7 January 2021

Activation of the Ral and phosphatidylinositol 3' kinase signaling pathways by the ras-related protein TC21.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205961

7 January 2021

Regulation of Ras signaling specificity by protein kinase C.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205961

7 January 2021

Dysregulation of phosphatidylinositol 3-kinase and downstream effectors in human breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205961

7 January 2021

Small GTP-binding proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205961

7 January 2021

PDK1 mediates growth factor-induced Ral-GEF activation by a kinase-independent mechanism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205961

7 January 2021

STAT proteins: novel molecular targets for cancer drug discovery

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205961

7 January 2021

Identification of BCAR3 by a random search for genes involved in antiestrogen resistance of human breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205961

7 January 2021

Tamoxifen resistance in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205961

7 January 2021

Stimulation of gene induction and cell growth by the Ras effector Rlf

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205961

7 January 2021

An Eph receptor regulates integrin activity through R-Ras

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205961

7 January 2021